Effect of dutasteride on microvessel density in benign prostatic hyperplasia.

Abstract

AIM Dutasteride, a dual 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH). However, its histopathological effects on the morphometrics of blood vessels and glands are still controversial. This study aimed to assess the histopathological effects of dutasteride in cases of BPH in a retrospective manner. PATIENTS AND METHODS… (More)

4 Figures and Tables

Topics

  • Presentations referencing similar topics